Market Place
Sourcing Support
All News #Library
Biotech
Henlius Doses First Patient in Next-Gen Tetra-Specific Platform
30 Apr 2026 //
FIRSTWORD PHARMA
Henlius Completes Phase 2/3 Trial Of Pimurutamab (HLX07)
24 Apr 2026 //
FIRSTWORD PHARMA
Inside Henlius` Global Growth Strategy
02 Feb 2026 //
FIERCE BIOTECH
FDA Approves POHERDY® as First PERJETA Biosimilar
17 Nov 2025 //
BUSINESSWIRE
Poherdy, First Biosimilar To Roche`s Perjeta, Scores FDA Nod
14 Nov 2025 //
FIERCE PHARMA
EC Approves Henlius, Organon`s BILDYOS & BILPREVDA Biosimilars
19 Sep 2025 //
PHARMAWEB
Henlius 2025 Global R&D Day: Powering Global Strategy
16 Apr 2025 //
PR NEWSWIRE
EMA Validates Henlius and Organon Filing for Perjeta Biosimilar
28 Mar 2025 //
BUSINESSWIRE
First Shipment of Henlius Trastuzumab to U.S.
02 Dec 2024 //
PR NEWSWIRE
Henlius and Intas receive Positive CHMP Opinion for HETRONIFLY
21 Sep 2024 //
PR NEWSWIRE
Henlius Xgeva® Prolia® Biosimilar: Ema Filings With Organon Validated
24 May 2024 //
BUSINESSWIRE
Henlius Reported Financial Results for the First Three Quarters of 2023
15 Nov 2023 //
PR NEWSWIRE
Henlius Deepens Collaboration with Intas to bring Serplulimab to Europe & India
27 Oct 2023 //
PR NEWSWIRE
Henlius Expands Collaboration with KGbio
12 Sep 2023 //
PR NEWSWIRE
Henlius 2023 H1 Results: Achieved record profits and RMB2.5 billion revenues
25 Aug 2023 //
PR NEWSWIRE
Fosun Pharma and Henlius Entered into an Agreement for Serplulimab in the US
07 Jan 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.